administration of UI018
KUP-UI018-103
Phase 1 small_molecule active
Quick answer
administration of UI018 for Hyperlipemia, Mixed is a Phase 1 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Hyperlipemia, Mixed
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active